Health Sector Headlines: From FDA Approvals to CEO Transitions

Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch amid investor pressure, and a court's ruling on Tennessee's abortion ban. Meanwhile, the WHO recommends front-of-package labels to curb obesity, and efforts continue to raise awareness about mpox vaccinations in Congo.

The U.S. Food and Drug Administration has approved Astellas' gastric cancer therapy, branded as Vyloy, in a notable health development. This treatment is designed for cancer that starts at the gastroesophageal junction and is used alongside chemotherapy.

CVS Health is under substantial change with the resignation of CEO Karen Lynch, driven by shareholder demands to enhance corporate performance. David Joyner, a seasoned company executive, steps in as the new CEO amid pressure from investors like Glenview Capital.

Additional health sector news includes the Congolese government's slowed rollout of mpox vaccines and a Tennessee ruling that relaxes the enforcement of abortion bans in certain medical emergencies. In policy developments, the WHO's guidelines suggest clearer nutritional labeling on food packaging to help combat global obesity rates.

(With inputs from agencies.)